[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:gastric-adenocarcinoma:claudin-18-isoform-a2":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Gastric Adenocarcinoma","Claudin-18 Isoform A2",3,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06901531","A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer",[12],"Phase 3","RECRUITING","2026-08-26T02:18:33.598205Z","2026-07-05T05:32:16.705484Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05365581","A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer",[20],"Phase 1","2026-08-26T02:17:42.501124Z","2026-07-05T05:32:16.805238Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT07546812","Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas",[27],"Phase 2","2026-08-26T02:16:10.529598Z","2026-07-19T19:36:05.144248Z"]